VOR VOR
Company Profile ↓Company Overview
VOR (VOR) is a publicly traded company listed on with a market capitalization of $862.30M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -46.98% |
| 6 Months: | +73.71% |
| 3 Months: | +43.49% |
| 1 Month: | +10.80% |
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)66.68 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 54.3% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 33.29M | 274.28M | 28.11M | 35.96M | 35.16M |
| Operating Income | -7.88M | -8.04M | -11.79M | -13.73M | -18.38M | -18.60M | -22.80M | -21.79M | -24.10M | -30.42M | -32.17M | -35.32M | -32.33M | -29.04M | -28.51M | -33.29M | -274.28M | -28.11M | -35.96M | -35.16M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -32.47M | -272.25M | -28.11M | -35.94M | -35.13M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -32.49M | -1.57B | -812.68M | 1.72B | -219.59M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | -7.85M | -8.04M | -11.79M | -13.72M | -18.37M | -18.55M | -22.74M | -21.66M | -23.79M | -28.43M | -29.98M | -33.19M | -30.80M | -27.84M | -27.56M | -32.49M | -1.57B | -812.68M | 1.72B | -219.59M |
| Diluted EPS | - | - | - | - | -0.50 | -0.50 | -0.61 | -0.58 | -0.63 | -0.43 | -0.45 | -0.49 | -0.45 | -0.41 | -8.05 | -5.21 | -251.20 | -121.63 | - | -5.11 |
| R&D Expense | 6.17M | 5.97M | 8.14M | 8.94M | 12.97M | 12.93M | 15.28M | 15.33M | 16.88M | 21.91M | 23.90M | 27.61M | 24.32M | 21.82M | 21.82M | 26.70M | 261.50M | 14.14M | - | 17.59M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | - | 93.42M | 126.04M | 121.19M | 371.64M |
| Operating Income | -43.37M | - | -93.42M | -126.04M | -121.19M | -371.64M |
| EBITDA | - | - | -90.89M | -122.54M | -117.66M | -368.75M |
| Interest Expense | - | - | - | - | - | - |
| Pretax Income | - | - | -92.09M | -117.86M | -116.91M | -695.98M |
| Tax Provision | - | - | - | - | - | - |
| Net Income | -43.34M | - | -92.09M | -117.86M | -116.91M | -695.98M |
| Diluted EPS | - | - | -46.60 | -35.00 | -34.03 | -70.50 |
| R&D Expense | 31.62M | 47.53M | 64.55M | 94.31M | 93.31M | 321.53M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | 75.91M | - | 299.37M | 198.13M | 142.89M | 464.13M |
| Current Assets | - | - | - | 236.95M | 140.80M | 96.51M | 458.11M |
| Cash & Equivalents | - | 48.54M | - | 57.71M | 31.36M | 81.95M | 396.49M |
| Inventory | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - |
| Total Liabilities | - | 27.64M | - | 48.76M | 47.40M | 46.23M | 628.44M |
| Current Liabilities | - | 10.21M | - | 13.12M | 15.57M | 18.61M | 25.17M |
| Long Term Debt | - | - | - | - | - | - | - |
| Total Debt | - | - | - | 38.91M | 35.66M | 31.83M | 3.00M |
| Total Equity | -17.43M | -59.06M | - | 250.61M | 150.72M | 96.66M | -164.31M |
| Shares Outstanding | - | - | - | 3.30M | 3.39M | 6.24M | 38.72M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -36.29M | - | -85.14M | -100.29M | -99.66M | -142.71M |
| Investing Cash Flow | -4.16M | - | -94.09M | 71.01M | 96.86M | -48.80M |
| Financing Cash Flow | 82.53M | - | 117.14M | 2.94M | 53.39M | 503.81M |
| Capital Expenditure | -4.16M | - | -8.46M | -1.07M | -229.00K | -941.00K |
| Free Cash Flow | -40.45M | - | -93.61M | -101.36M | -99.89M | -143.65M |
| Net Change in Cash | - | - | -62.09M | -26.35M | 50.59M | 312.29M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - |
| ROE % | 73.4% | - | -36.7% | -78.2% | -120.9% | 423.6% |
| ROCE % | -66.0% | - | -32.6% | -69.0% | -97.5% | -84.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for VOR
Vor Biopharma Stock Price Forecast. Should You Buy VOR? - StockInvest.us
<a href="https://news.google.com/rss/articles/CBMiR0FVX3lxTE9PaWNSRVQwaFk5eldjUmE3S1YyRWlTaWlwNlpkUVdHT3VFNFgwOVpVd08xb2QxemVNenNvQXZZQmcxSWVyR0tB?oc=5" target="_blank">Vor Biopharma Stock Price Forecast. Should You Buy VOR?</a> …
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Yahoo! Finance Canada
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxNM0EtdktNQmM2emtGSlFBTkxtUnFDM2lELVZLUmJyUlhGeTZaMkUxOERod3dpNnZwdDFKd2JxbDg0ZUQtc1duMEtYVzd0Nk1NaVZQTjlXNmxzaXBEXzhtMGlaV3JDVW9neG5mRVc5cVN3TWJZbm5rTmxoVHJHMDdNeTk2X1Q4VGFi?oc=5"…
Vor Biopharma (VOR) Stock May Already Look Fully Priced On Pipeline Hopes - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxQRFh0YnVOcm9rOUFWaUxhUFV0RklmTWFoOGxsYm92TE1KWGlSdW1GM0h4YU8tbTZxb3dSZTc3VzctdVJFcmZEQU5rVXRuTHVmT2dNX1VESjNmNTJfdmtIRHRMSTJBNWNTQUhJWGhSV21NR1A4NjN2d2ItSldiMmpQa04wdDJvb3ExT2FWTl…
Price to book forward of Vor Biopharma Inc. – NASDAQ:VOR - TradingView
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxOb09sUDVJWTF3V3ZBempQMW1aWkMzU1ZBMXQyYTdXT2Y5cjFnX1c5OXZrNUlIUnJIUlcwdGRRUmQ5TzdoWVlIRlNlcVY5OEdNa3BpOFdKeFFmb1BjMDc5a2N2T0tESFBzQ1Z4QjNVN1ZnbHNCMk15SHJoUG1lenFlV083VndSVDF1bVdQQW…
BlackRock (VOR) reports 5.7% beneficial ownership stake in VOR Biopharma Inc - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPZ3BGckU1MFRYZVVOOVNfeDY4NXhKbUxFbjNqXzRpbi1LMjkzNFh5ZmxNSXY4RzF3cS1ndm5KOUZTVWN6M2N3c3E1YmJqS0sya1l3cUpNdU1zQ0I1ZGpnODhHal9oYkE1S1V2M1Zyd0UwaS1wUWFOOUhqU0s5TXp2bUFtX1pnZHNlc0ZSNz…
Vor Bio grants stock options for 32,550 shares, RSUs for 6,900 shares to new hires under inducement plan - Bitget
<a href="https://news.google.com/rss/articles/CBMiY0FVX3lxTE01U3J2dUlnUzREcFhoQkIyUkpiTVRoN1pWTUVMcDd6NGlCZW1wY3duY3duOWI2WmplbkEzd0piMVIzYzlacl9lM1NCWElZTnBQMzRhOWQwWUZsTVg4NndLM3NzZ9IBY0FVX3lxTE01U3J2dUlnUzREcFhoQkIyUkpiTVRoN1pWTUVMcDd6NG…
VOR — Frequently Asked Questions
What is the current share price of VOR?
As of 2026-08-05 17:25 PDT, VOR trades at $22.27 on NASDAQ/NYSE. Its 52-week range is $6.86 to $48.72.
What is the market capitalisation of VOR?
VOR has a market capitalisation of $862.30M on NASDAQ/NYSE.
What is the P/E ratio of VOR?
VOR trades at a trailing price-to-earnings (P/E) ratio of -0.32. Its price-to-book (P/B) ratio is -5.25.
Is VOR a good stock to buy?
This page provides a data-driven analysis of VOR, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.